Here is a stock report on five publicly traded GI/endoscopy companies for Feb. 2 to Feb. 6.
• AbbVie: $57.26 per share (down 1.26 percent)
• Boston Scientific: $15.14 per share (up 0.7 percent)
• FUJIFILM Holdings: 3,981 per share (JPY) (up 0.49 percent)
• Olympus: 4,125 per share (JPY) (up 2.74 percent)
• Salix Pharmaceuticals: $142.17 per share (up 0.67 percent)
More articles on gastroenterology:
6 gastroenterologists serving as CMOs
New drugs, screening tactics could nearly eliminate HCV by 2036
Preparing for potential GI payment cuts: 3 quick tips
Miami-based Gastro Health has named Chris Fourment, MD, vice president of clinical research, according to an April 21 news release…
Pop singer Lance Bass has joined a long list of celebrities encouraging patients to get screened for colon cancer. On…
The National Institutes of Health has withdrawn renewal grant applications for the Consortium of Eosinophilic Gastrointestinal Disease Researchers. Patient advocacy…
Comments are closed.